Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Frontiers in Cellular and Infection Microbiology
|
May 15, 2018
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-<i>Mycobacterium tuberculosis</i> Strains
H M Adnan Hameed, Md Mahmudul Islam, Chiranjibi Chhotaray, et al.
Journal of Medicinal Chemistry
|
August 12, 2024
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9
Changwei Wang, Mi Wang, Yu Wang, et al.
Journal of Proteome Research
|
June 22, 2016
Identification of Lysine Acetylation in Mycobacterium abscessus Using LC-MS/MS after Immunoprecipitation
Jintao Guo, Changwei Wang, Yi Han, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
January 25, 2017
Drug resistance mechanisms and novel drug targets for tuberculosis therapy
Md Mahmudul Islam, H M Adnan Hameed, Julius Mugweru, et al.
Cancer Letters
|
July 31, 2020
A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells
Dade Rong, Changwei Wang, Xiaomei Zhang, et al.
International Journal of Molecular Sciences
|
January 11, 2022
The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
Karolina Seborova, Alzbeta Kloudova-Spalenkova, Kamila Koucka, et al.
Antimicrobial Agents and Chemotherapy
|
March 9, 2016
Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis
Gaëlle Guiewi Makafe, Yuanyuan Cao, Yaoju Tan, et al.
Nature Communications
|
February 2, 2019
The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
Yang Liu, Yamin Gao, Jianxiong Liu, et al.
Journal of Medicinal Chemistry
|
October 6, 2021
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry
|
June 26, 2020
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Frontiers in Cellular and Infection Microbiology
|
May 15, 2018
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-<i>Mycobacterium tuberculosis</i> Strains
H M Adnan Hameed, Md Mahmudul Islam, Chiranjibi Chhotaray, et al.
Journal of Medicinal Chemistry
|
August 12, 2024
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9
Changwei Wang, Mi Wang, Yu Wang, et al.
Journal of Proteome Research
|
June 22, 2016
Identification of Lysine Acetylation in Mycobacterium abscessus Using LC-MS/MS after Immunoprecipitation
Jintao Guo, Changwei Wang, Yi Han, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
January 25, 2017
Drug resistance mechanisms and novel drug targets for tuberculosis therapy
Md Mahmudul Islam, H M Adnan Hameed, Julius Mugweru, et al.
Cancer Letters
|
July 31, 2020
A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells
Dade Rong, Changwei Wang, Xiaomei Zhang, et al.
International Journal of Molecular Sciences
|
January 11, 2022
The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
Karolina Seborova, Alzbeta Kloudova-Spalenkova, Kamila Koucka, et al.
Antimicrobial Agents and Chemotherapy
|
March 9, 2016
Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis
Gaëlle Guiewi Makafe, Yuanyuan Cao, Yaoju Tan, et al.
Nature Communications
|
February 2, 2019
The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
Yang Liu, Yamin Gao, Jianxiong Liu, et al.
Journal of Medicinal Chemistry
|
October 6, 2021
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry
|
June 26, 2020
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Page
of 11